Literature DB >> 24685690

Lipid accumulation in dysferlin-deficient muscles.

Miranda D Grounds1, Jessica R Terrill2, Hannah G Radley-Crabb3, Terry Robertson4, John Papadimitriou4, Simone Spuler5, Tea Shavlakadze2.   

Abstract

Dysferlin is a membrane associated protein involved in vesicle trafficking and fusion. Defects in dysferlin result in limb-girdle muscular dystrophy type 2B and Miyoshi myopathy in humans and myopathy in A/J(dys-/-) and BLAJ mice, but the pathomechanism of the myopathy is not understood. Oil Red O staining showed many lipid droplets within the psoas and quadriceps muscles of dysferlin-deficient A/J(dys-/-) mice aged 8 and 12 months, and lipid droplets were also conspicuous within human myofibers from patients with dysferlinopathy (but not other myopathies). Electron microscopy of 8-month-old A/J(dys-/-) psoas muscles confirmed lipid droplets within myofibers and showed disturbed architecture of myofibers. In addition, the presence of many adipocytes was confirmed, and a possible role for dysferlin in adipocytes is suggested. Increased expression of mRNA for a gene involved in early lipogenesis, CCAAT/enhancer binding protein-δ, in 3-month-old A/J(dys-/-) quadriceps (before marked histopathology is evident), indicates early induction of lipogenesis/adipogenesis within dysferlin-deficient muscles. Similar results were seen for dysferlin-deficient BLAJ mice. These novel observations of conspicuous intermyofibrillar lipid and progressive adipocyte replacement in dysferlin-deficient muscles present a new focus for investigating the mechanisms that result in the progressive decline of muscle function in dysferlinopathies.
Copyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24685690     DOI: 10.1016/j.ajpath.2014.02.005

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

1.  Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.

Authors:  Stephanie L Sellers; Nadia Milad; Zoe White; Chris Pascoe; Rayleigh Chan; Geoffrey W Payne; Chun Seow; Fabio Rossi; Michael A Seidman; Pascal Bernatchez
Journal:  J Lipid Res       Date:  2017-11-25       Impact factor: 5.922

2.  Lkb1 deletion promotes ectopic lipid accumulation in muscle progenitor cells and mature muscles.

Authors:  Tizhong Shan; Pengpeng Zhang; Pengpeng Bi; Shihuan Kuang
Journal:  J Cell Physiol       Date:  2015-05       Impact factor: 6.384

3.  Structure-Based Designed Nano-Dysferlin Significantly Improves Dysferlinopathy in BLA/J Mice.

Authors:  Telmo Llanga; Nadia Nagy; Laura Conatser; Catherine Dial; R Bryan Sutton; Matthew L Hirsch
Journal:  Mol Ther       Date:  2017-06-16       Impact factor: 11.454

4.  Dysferlin deficiency alters lipid metabolism and remodels the skeletal muscle lipidome in mice.

Authors:  Vanessa R Haynes; Stacey N Keenan; Jackie Bayliss; Erin M Lloyd; Peter J Meikle; Miranda D Grounds; Matthew J Watt
Journal:  J Lipid Res       Date:  2019-06-15       Impact factor: 5.922

5.  Intermittent Glucocorticoid Dosing Improves Muscle Repair and Function in Mice with Limb-Girdle Muscular Dystrophy.

Authors:  Mattia Quattrocelli; Isabella M Salamone; Patrick G Page; James L Warner; Alexis R Demonbreun; Elizabeth M McNally
Journal:  Am J Pathol       Date:  2017-08-18       Impact factor: 4.307

6.  Myofiber damage precedes macrophage infiltration after in vivo injury in dysferlin-deficient A/J mouse skeletal muscle.

Authors:  Joseph A Roche; Mohan E Tulapurkar; Amber L Mueller; Nico van Rooijen; Jeffrey D Hasday; Richard M Lovering; Robert J Bloch
Journal:  Am J Pathol       Date:  2015-04-25       Impact factor: 4.307

7.  Annexin A2 links poor myofiber repair with inflammation and adipogenic replacement of the injured muscle.

Authors:  Aurelia Defour; Sushma Medikayala; Jack H Van der Meulen; Marshall W Hogarth; Nicholas Holdreith; Apostolos Malatras; William Duddy; Jessica Boehler; Kanneboyina Nagaraju; Jyoti K Jaiswal
Journal:  Hum Mol Genet       Date:  2017-06-01       Impact factor: 6.150

Review 8.  Engineered skeletal muscles for disease modeling and drug discovery.

Authors:  Jason Wang; Alastair Khodabukus; Lingjun Rao; Keith Vandusen; Nadia Abutaleb; Nenad Bursac
Journal:  Biomaterials       Date:  2019-08-08       Impact factor: 12.479

9.  Sex differences in the involvement of skeletal and cardiac muscles in myopathic Ano5-/- mice.

Authors:  Steven Foltz; Fang Wu; Nasab Ghazal; Jennifer Q Kwong; H Criss Hartzell; Hyojung J Choo
Journal:  Am J Physiol Cell Physiol       Date:  2022-01-12       Impact factor: 4.249

10.  Insights into lipid accumulation in skeletal muscle in dysferlin-deficient mice.

Authors:  Anil K Agarwal; Katie Tunison; Matthew A Mitsche; Jeffrey G McDonald; Abhimanyu Garg
Journal:  J Lipid Res       Date:  2019-10-25       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.